Skip to content

EBITDA margin at other companies

Humana logo
HumanaHUM
3.4%-1.7pp
CVS Health logo
CVS HealthCVS
2.6%-1.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
5.2%-4.0pp
Alignment Healthcare logo
Alignment HealthcareALHC
1.6%+1.1pp
Astrana Health logo
Astrana HealthASTH
4%-0.9pp
Agilon Health logo
Agilon HealthAGL
-7%+6.8pp

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Calculated from Clover Health Investments’s reported figures.

Based on trailing twelve months.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's EBITDA margin?
Clover Health Investments (CLOV) reported EBITDA margin of -2.5% in Q1 2026.
How has Clover Health Investments's EBITDA margin changed year-over-year?
Clover Health Investments's EBITDA margin decreased by 62.4% year-over-year, from -1.5% to -2.5%.
What is the long-term trend for Clover Health Investments's EBITDA margin?
Over 4 years (2020 to 2025), Clover Health Investments's EBITDA margin has grown at a -24.9% compound annual growth rate (CAGR), from -13.7% to -4.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.